Three South African firms may produce Gilead's HIV injection amid criticism of its rollout

Three South African firms may produce Gilead's HIV injection amid criticism of its rollout

Trials show lenacapavir can all but eliminate the risk of HIV infection. Yet in the countries where it was tested, most people can't afford it.